fep blue glp-1 coverage 2025 Who Gets the Shot? Access by State Fep Blue Cross Blue Sheils

The maximum dose should not exceed 2,000 mg daily

Brazil records 28.9% growth, reflecting rapid expansion of private insurance coverage and growing physician adoption of obesity pharmacotherapy

if the prevention trials confirm this, the "brain bonus" for our patients already on these medications for diabetes or weight management could be one of the most significant public health wins in recent memory

Healthy habits remain the foundation of lifelong metabolic wellness

In addition, in January 2025, Medicare announced it will include semaglutide products (Ozempic, Rybelsus, and Wegovy) in its second round of drug price negotiations, treating all three brands as a single drug due to their shared active ingredient.28 With negotiated prices set to take effect in 2027, this could significantly reduce costs for Medicare beneficiaries